Almotriptan: new option to knock migraine on the head

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1238, 2000-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular safety profile of almotriptan, a new indolic derivative for the treatment of migraine

By Gras J. Cardelus I. Llenas J. Palacios J.M.

European Journal of Pharmacology, Vol. 410, Iss. 1, 2000-12 ,pp. : 53-59

Elsevier

Access to resources Recommend Favorite

Spotlight on Almotriptan in Migraine

By Keam S.J. Goa K.L. Figgitt D.P.

CNS Drugs, Vol. 16, Iss. 7, 2002-01 ,pp. : 501-507

Adis International

Access to resources Recommend Favorite

Almotriptan for menstrually related migraine

By Bussone Gennaro Allais Gianni Castagnoli Gabellari Ilaria Benedetto Chiara

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 12, 2011-08 ,pp. : 1933-1943

Informa Healthcare

Access to resources Recommend Favorite

Almotriptan cost beneficial for migraine in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 372, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Almotriptan: aiming for early treatment in migraine

Inpharma, Vol. 1, Iss. 1486, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite